Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28041 | 176 | 44.4 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ENDOCAN | Author keyword | 81 | 87% | 23% | 40 |
2 | ESM 1 | Author keyword | 27 | 92% | 6% | 11 |
3 | ENDOTHELIAL CELL SPECIFIC MOLECULE 1 | Author keyword | 18 | 89% | 5% | 8 |
4 | ENDOTHELIAL CELL SPECIFIC MOLECULE | Author keyword | 1 | 100% | 1% | 2 |
5 | U416 | Address | 1 | 11% | 5% | 9 |
6 | U774 | Address | 1 | 15% | 3% | 5 |
7 | CLIN VOJVODINA MED | Address | 1 | 50% | 1% | 1 |
8 | ECM 1 | Author keyword | 1 | 50% | 1% | 1 |
9 | INTERNAL MED HIST MED MED ETH | Address | 1 | 50% | 1% | 1 |
10 | LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENDOCAN | 81 | 87% | 23% | 40 | Search ENDOCAN | Search ENDOCAN |
2 | ESM 1 | 27 | 92% | 6% | 11 | Search ESM+1 | Search ESM+1 |
3 | ENDOTHELIAL CELL SPECIFIC MOLECULE 1 | 18 | 89% | 5% | 8 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE+1 |
4 | ENDOTHELIAL CELL SPECIFIC MOLECULE | 1 | 100% | 1% | 2 | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE | Search ENDOTHELIAL+CELL+SPECIFIC+MOLECULE |
5 | ECM 1 | 1 | 50% | 1% | 1 | Search ECM+1 | Search ECM+1 |
6 | LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN | 1 | 50% | 1% | 1 | Search LEUKOCYTE+FUNCTION+ASSOCIATED+ANTIGEN | Search LEUKOCYTE+FUNCTION+ASSOCIATED+ANTIGEN |
7 | PROGNOSTIC SURVIVAL | 1 | 50% | 1% | 1 | Search PROGNOSTIC+SURVIVAL | Search PROGNOSTIC+SURVIVAL |
8 | SONE | 1 | 50% | 1% | 1 | Search SONE | Search SONE |
9 | VEZF1 | 1 | 22% | 1% | 2 | Search VEZF1 | Search VEZF1 |
10 | EMBRYOID BODY DIFFERENTIATION | 0 | 33% | 1% | 1 | Search EMBRYOID+BODY+DIFFERENTIATION | Search EMBRYOID+BODY+DIFFERENTIATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ESM 1 | 82 | 92% | 19% | 33 |
2 | CELL SPECIFIC MOLECULE 1 | 59 | 78% | 22% | 39 |
3 | ENDOCAN EXPRESSION | 20 | 100% | 5% | 9 |
4 | VASCULAR ENDOCAN | 15 | 82% | 5% | 9 |
5 | ENDOCAN | 5 | 60% | 3% | 6 |
6 | HUMAN ICAM 2 PROMOTER | 2 | 50% | 2% | 3 |
7 | WILLEBRAND FACTOR GENE | 2 | 28% | 3% | 5 |
8 | MURINE PREPROENDOTHELIN 1 PROMOTER | 1 | 50% | 1% | 1 |
9 | PRODUCT RECEPTOR COMPLEX | 1 | 50% | 1% | 1 |
10 | SELECTIN GENE | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Endothelial cell gene regulation | 2005 | 61 | 26 | 46% |
Endocan: A New Molecule Playing a Role in the Development of Hypertension and Chronic Kidney Disease? | 2014 | 0 | 19 | 79% |
Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? | 2011 | 34 | 130 | 11% |
Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy | 2006 | 77 | 84 | 11% |
Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium | 2006 | 46 | 195 | 14% |
Epigenetic regulation of vascular endothelial gene expression | 2008 | 73 | 135 | 5% |
Phenotypic heterogeneity of the endothelium I. Structure, function, and mechanisms | 2007 | 445 | 157 | 6% |
Transcriptional targeting of tumor endothelial cells for gene therapy | 2009 | 16 | 154 | 11% |
Endothelial heterogeneity in the umbilico-placental unit: DNA methylation as an innuendo of epigenetic diversity | 2014 | 2 | 96 | 11% |
Gene Regulation in the Vascular Endothelium: Why Epigenetics Is Important for the Kidney | 2012 | 3 | 101 | 10% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | U416 | 1 | 11% | 5.1% | 9 |
2 | U774 | 1 | 15% | 2.8% | 5 |
3 | CLIN VOJVODINA MED | 1 | 50% | 0.6% | 1 |
4 | INTERNAL MED HIST MED MED ETH | 1 | 50% | 0.6% | 1 |
5 | UMR 5075 CEA | 1 | 50% | 0.6% | 1 |
6 | VASC MOL MED | 1 | 50% | 0.6% | 1 |
7 | MOL VASC MED MED | 1 | 29% | 1.1% | 2 |
8 | ANTIINFLAMMATORY IMMUNOL PHARMACOL | 1 | 25% | 1.1% | 2 |
9 | GENE OURCE UTILIZAT SEVERE DIS ANHUI P | 1 | 22% | 1.1% | 2 |
10 | BEIJING CANC HOSP TISSUE BANK | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000125439 | CXXC5//THEOPHYLLAMINE//BIOCHIP ARRAY |
2 | 0.0000087799 | ANGIOPOIETIN 2//TIE2//ANGIOPOIETIN |
3 | 0.0000081187 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
4 | 0.0000076473 | MGDC//VERRUCARIN A//RADIAT TUMOR PHYSIOL |
5 | 0.0000072561 | ETS 1//ETS DOMAIN//ETS FAMILY |
6 | 0.0000069935 | HEART ENDOTHELIAL CELLS//MICROVESSEL ENDOTHELIUM//NON MHC |
7 | 0.0000068543 | ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE//ENOS GENE//ENOS POLYMORPHISM |
8 | 0.0000066662 | NF Y//NF YB//CCAAT BOX |
9 | 0.0000064190 | VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TEM7 |
10 | 0.0000060256 | DRS GENE//HEPATIC LEUKEMIA FACTOR//E2A HLF |